09:00 AM EDT, 03/15/2024 (MT Newswires) -- NeuPath Health Inc. (NPTH.V) said Friday that it narrowed its fourth-quarter net and comprehensive loss to $368,000 from a loss of $1.9 million a year earlier.

Revenue for the quarter ended Dec. 31, 2023, was $16.8 million, up from $16.1 million a year earlier.

Adjusted EBITDA for Q4 was $761,000, down from $808,000 a year ago.

As at Dec. 31, 2023, the company's net debt was $2.9 million, down from $5.3 million as at Dec. 31, 2022.

NeuPath operates a network of healthcare clinics and related businesses focused on improved access to care and outcomes for patients by leveraging best-in-class treatments and delivering patient-centered multidisciplinary care.